DERMAPHARM HOLDING SE
Ownership & governance
Executives 3Directors 3Avg age 69Avg tenure 8y
HF
Hans-Georg Feldmeier
Chief Executive Officer
Age 64Since 2017-07-31Profile →
+5
Executives3
Board of directors3
Shareholders5
| Name | Stake | Shares |
|---|---|---|
| Wilhelm Beier | 88.57 % | 43,879,600 |
| DERMAPHARM HOLDING SE | 8.678 % | 4,299,190 |
| Mawer Investment Management Ltd. | 3.229 % | 1,599,728 |
| Paladin Asset Management Investmentaktiengesellschaft TGV | 0.1302 % | 64,500 |
| KB - Vermögensverwaltung GmbH | 0.0646 % | 32,000 |
Catalog · 2026-07-09
Registry officers6
| Name | Role | Since | Shares |
|---|---|---|---|
| Christof Dreibholz | Director of Finance/CFO | 2022-10-31 | - |
| Hans-Georg Feldmeier | Chief Executive Officer | 2017-07-31 | - |
| Wilhelm Beier | Chairman | 2017-07-31 | - |
| Erwin Kern | Director/Board Member | 2017-07-31 | - |
| Lothar Maximilian Lanz | Director/Board Member | 2017-12-31 | - |
| Britta Hamberger | Investor Relations Contact | 2018-11-30 | - |
Registry · as of 2026-07-09
Group companies
| Name | Category |
|---|---|
| Strathmann GmbH & Co. KG | Pharmaceuticals: Major |
| Allergopharma AG | Pharmaceuticals: Major |
| Dermapharm AG | Pharmaceuticals: Major |
| Dermapharm AG (Switzerland) | — |
| mibe GmbH | Pharmaceuticals: Major |
Institutional (13F)
Loading Form 13F holders…
Fund membership
Loading fund baskets…
Street consensus
Consensus noneMean target 51Range 44–60Analysts 4
44Mean 5160
- Strong buy 2
- Buy 2
- Hold 2
Firm rows and rating mix from Yahoo Finance; mean target is Yahoo’s aggregate until OpenFilings derives consensus from broker rows.